Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,958.12
    +2,941.41 (+3.46%)
     

  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Today’s Research Reports on Concordia International, GeneNews, Medicure and Calyx Ventures

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 5, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Concordia International Corp.
https://rdinvesting.com/news/?ticker=CXR.TO

GeneNews Ltd.
https://rdinvesting.com/news/?ticker=GEN.TO

Medicure Inc.
https://rdinvesting.com/news/?ticker=MPH.V

Calyx Ventures Inc.
https://rdinvesting.com/news/?ticker=CYX.V

ADVERTISEMENT

Concordia International's stock moved 1.22% higher Friday, to close the day at $0.83. The stock recorded a trading volume of 32,803 shares, which was below its three months average volume of 263,051 shares. In the last year, Concordia International's shares have traded in a range of 0.58 - 3.05. The share price has gained 43.10% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.86 is below its 200-day moving average of $1.03. Shares of Concordia International have gained approximately 1.22 percent year-to-date.

Access RDI's Concordia International Corp. Research Report at:
https://rdinvesting.com/news/?ticker=CXR.TO

On Friday, shares of GeneNews recorded a trading volume of 92,948 shares, which was below the three months average volume of 638,500 shares. The stock ended the day 10.00% higher at 0.11. The share price has gained 37.50% from its 52 week low with a 52 week trading range of 0.08 - 0.53.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.13 is at its 200-day moving average of $0.13. Shares of GeneNews have gained approximately 62.54 percent year-to-date.

Access RDI's GeneNews Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=GEN.TO

Medicure's stock edged 0.69% lower Friday, to close the day at $7.20. The stock recorded a trading volume of 100,450 shares, which was above its three months average volume of 20,640 shares. In the last year, Medicure's shares have traded in a range of 6.00 - 10.16. The share price has gained 20.00% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.28 is below its 200-day moving average of $7.69. Shares of the company are trading at a Price to Earnings ratio of 8.11. Shares of Medicure have fallen approximately 3.36 percent year-to-date.

Access RDI's Medicure Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MPH.V

On Friday, shares of Calyx Ventures recorded a trading volume of 82,266 shares, which was below the three months average volume of 1,359,200 shares. The stock ended the day flat at 0.15. The share price has gained 200.00% from its 52 week low with a 52 week trading range of 0.05 - 0.42.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.20 is greater than its 200-day moving average of $0.16. Shares of Calyx Venture have fallen approximately 47.37 percent year-to-date.

Access RDI's Calyx Ventures Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CYX.V

Our Actionable Research on Concordia International Corp. (TSX:CXR.TO), GeneNews Ltd. (TSX:GEN.TO), Medicure Inc. (TSXV:MPH.V) and Calyx Ventures Inc. (TSXV:CYX.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com